[lemma=fast] [tag=NN] □ □
[lemma=fast] [tag=NN] [□] □
[lemma=fast] [tag=NN] □? □
Phenoxodiol ( Marshall Edwards Inc ., New South Wales , Australia ) also has been granted fast track status for the treatment of recurrent ovarian cancer . Trimeris ’ second fusion inhibitor product candidate , T-1249 , has received fast track status from the FDA and is in Phase I / II clinical testing . Trimeris ' second fusion inhibitor product candidate , T-1249 , has received fast track status from the FDA and is in Phase I / II clinical testing .